Sanjay Shukla | President, Chief Executive Officer |
Jill Broadfoot | Chief Financial Officer |
Zegbeh Jallah | ROTH Capital |
Hartaj Singh | Oppenheimer |
Joe Pantginis | H.C. Wainwright |
Good afternoon, ladies and gentlemen and welcome to the aTyr Pharma, Second Quarter 2020 Conference Call. At this time all participants are in a listen-only mode. [Operator Instructions] As a reminder to our conference call, this conference is being recorded for replay purposes. It is now my pleasure to hand the conference over to Jill Broadfoot, aTyr's Chief Financial Officer. Ms.